INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.48 Cr | ₹1.22 Cr | ₹6.29 Cr | ₹2.41 Cr | ₹1.46 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.48 Cr |
| Mar2024 | ₹1.22 Cr |
| Mar2023 | ₹6.29 Cr |
| Mar2022 | ₹2.41 Cr |
| Mar2021 | ₹1.46 Cr |
How is Cash Flow from Financing Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.48 Cr | Negative | |
| Mar2024 | ₹1.22 Cr | -80.68 | |
| Mar2023 | ₹6.29 Cr | 160.95 | |
| Mar2022 | ₹2.41 Cr | 64.96 | |
| Mar2021 | ₹1.46 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹268.1 Cr | -0.7% | 2.5% | -49.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,270.6 Cr | -4% | 1.1% | -31% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,174.0 Cr | -3.2% | -5% | 13.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,962.1 Cr | -8% | -8% | -17.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,252.1 Cr | -2.4% | -5.2% | -28.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹455.5 Cr | -3.4% | -19.8% | 15.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.7% |
2.5% |
-49.9% |
| SENSEX | -1.4% |
1.7% |
4.8% |
You may also like the below Video Courses